Foresite Capital
Startup rounds since 2012 with a Foresite Capital investor on the board, and the firm's own fund filings.
Raises
20
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
6
fund filings under the firm's name
Rounds
- Eikon Therapeutics, Inc.$351M
- Alumis Inc.$129M
- Eikon Therapeutics, Inc.$141M
- Eikon Therapeutics, Inc.$518M
- Interline Therapeutics, Inc.$50M
- FL2020-004, Inc.$1.5K
- Eikon Therapeutics, Inc.$103M
- FL2021-001, Inc.$60M
- Interline Therapeutics, Inc.$32.5M
- FL2021-001, Inc.$10.5M
- Interline Therapeutics, Inc.$10.1M
- Pardes Biosciences, Inc$51.6M
- Fulcrum Therapeutics, Inc.$80M
- Tarsa Therapeutics, Inc.$1.64M
- Tarsa Therapeutics, Inc.$1.25M
- Tarsa Therapeutics, Inc.$2M
- Allergen Research Corp$80M
- Wavetec Vision Systems Inc$2.89M
- Wavetec Vision Systems Inc$750K
- Tarsa Therapeutics, Inc.$13.8M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 1 | 0 |
| 2024 | 1 | — |
| 2023 | 1 | — |
| 2022 | 1 | — |
| 2021 | 8 | — |
| 2018 | 1 | — |
| 2017 | 1 | — |
| 2016 | 2 | — |
| 2015 | 1 | — |
| 2014 | 2 | — |
| 2012 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Foresite Capital Fund VI (Feeder), LP | 25 Oct 2023 | Open-ended | $84.5M |
| Foresite Capital Fund VI LP | 23 Jun 2023 | Open-ended | $551M |
| Foresite Capital VI-A, LLC | 20 Dec 2021 | $17.2M | — |
| Foresite Capital Fund V, L.P. | 25 Feb 2021 | $743M | $743M |
| Foresite Capital Opportunity Fund V, L.P. | 25 Feb 2021 | $186M | $186M |
| Foresite Capital III-A, LLC | 26 Mar 2012 | $10.9M | $10.9M |
Listed because a Foresite Capital fund's filing names a director of each company. A name match is not a verified identity.